Polyneuropathy (paresthesia, motor weakness, sensory disturbance), organomegaly (hepatomegaly, lymphadenopathy), endocrinopathy (testicular atrophy, gynecomastia), paraproteinemia (M-protein), skin changes (hyperpigmentation, hypertrchosis), peripheral edema. This evidence concerns the gene MYOM2 and Gynecomastia.